John E Kao, Director, Chief Executive Officer, on April 07, 2026, sold 250,000 shares in Alignment Healthcare (ALHC) for $5,252,911. Following the Form 4 filing with the SEC, Kao has control over a total of 3,889,509 common shares of the company, with 1,784,868 shares held directly and 2,104,641 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026024289/xslF345X05/wk-form4_1775684887.xml
-- John E Kao, Director, Chief Executive Officer, on April 07, 2026, sold 250,000 shares in Alignment Healthcare (ALHC) for $5,252,911. Following the Form 4 filing with the SEC, Kao has control over a total of 3,889,509 common shares of the company, with 1,784,868 shares held directly and 2,104,641 controlled indirectly.
SEC Filing: